M-L Dahl - Concepedia

Author

M-L Dahl

Karolinska Institutet

Also Known As

M L Dahl, M-L Dahl, ML Dahl, M‐L. Dahl

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital Uppsala University Uppsala University Hospital

About

M-L Dahl is an author at Karolinska Institutet specializing in medicine, hematology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	212
2	Public Health	1	1	142
3	Social Sciences	1	1	28
4	Epidemiology	1	1	142
5	Immunology	1	1	42

M-L Dahl

Publications

870

Citations

H-Index

Page 1

	Year	Citations
Clozapine disposition covaries with CYP1A2 activity determined by a caffeine test. Leif Bertilsson, JA Carrillo, M-L Dahl, British Journal of Clinical Pharmacology	1994	306
Interphenotype differences in disposition and effect on gastrin levels of omeprazole—suitability of omeprazole as a probe for CYP2C19. Ming Chang, Gunnel Tybring, M-L Dahl, British Journal of Clinical Pharmacology	1995	184
A PK–PD Model for Predicting the Impact of Age, CYP2C9, and VKORC1 Genotype on Individualization of Warfarin Therapy Anna‐Karin Hamberg, M-L Dahl, Martina Barban, Clinical Pharmacology & Therapeutics Disease ProgressionGenetic EpidemiologyHuman PolymorphismPharmacotherapyPk–pd Model	2007	142
Pharmacodynamics of Carbamazepine-mediated Induction of CYP3A4, CYP1A2, and Pgp as Assessed by Probe Substrates Midazolam, Caffeine, and Digoxin M-L Dahl, Jonas Cederberg, MO Karlsson, Clinical Pharmacology & Therapeutics	2007	94
Patterns of drug treatment of schizophrenic patients in Estonia, Spain and Sweden. R A Kiivet, Adrián LLerena, M-L Dahl, British Journal of Clinical Pharmacology	1995	59
Intra-individual variation and sex differences in gene expression of cytochromes P450 in circulating leukocytes Niklas Finnström, Birgitta Ask, M-L Dahl, The Pharmacogenomics Journal GeneticsImmunologySex DifferencesHematologyIntra-individual Variation	2002	42
Influence of FMO1 and 3 polymorphisms on serum olanzapine and its N-oxide metabolite in psychiatric patients Mao Mao Söderberg, Tore Haslemo, Espen Molden, The Pharmacogenomics Journal PsychiatryMedicinePsychotropic MedicationPsychiatric GeneticsSerum Olanzapine	2012	28
Disposition of debrisoquine and nortriptyline in Korean subjects in relation to <i>CYP2D6</i> genotypes, and comparison with Caucasians P.A. Van Dalen, M-L Dahl, Roh Hk, British Journal of Clinical Pharmacology	2003	15

Page 1